Manuscript preparation · JAPST

Instructions for Authors

Use these requirements to prepare the manuscript file, pharmaceutical evidence, figures, declarations, references and submission package.

Article formats: Six format groups
Abstract: Up to 250 words
Keywords: 5–12
Figures: 300 dpi or higher

Release profile

JAPST · Pharmaceutical science, technology and practice

Before submission

Confirm subject fit, originality, authorship and the article type before preparing the final files.

Subject fit

A submission should make a clear contribution to pharmaceutical knowledge, technology, medicine safety or pharmacy practice. A new formulation or manufacturing process is not required for every study.

Read the Aims and Scope

Originality and preprints

The manuscript must not be under consideration by another journal. Disclose any preprint and explain material changes made after posting.

Authorship

Confirm that every author meets the journal's contribution and accountability requirements, approves the submitted version and agrees to the author order.

Files to prepare

Main manuscript in DOCX format
Separate title-page information where double-blind review is requested
Figures at publication quality and editable tables
Cover letter and required declarations
Supporting information where applicable

Article types and length guidance

Choose the type that matches the scholarly contribution; every type must remain within the journal scope.

Original research articles

Experimental, analytical, computational, clinical, observational and pharmacy-practice studies addressing a defined pharmaceutical question.

Review articles

Critical narrative reviews, focused reviews, systematic reviews and meta-analyses with a clear question, transparent methods and balanced interpretation.

Case reports

Well-documented cases concerning adverse drug reactions, interactions, medication errors, pharmacotherapy or pharmaceutical care, with appropriate consent and cautious interpretation.

Short communications and technical notes

Concise reports of a focused finding or method, with enough evidence to support the stated contribution.

Methods and protocols

Pharmaceutical methods or study protocols with a clear rationale, sufficient methodological detail and evaluation appropriate to their purpose.

Perspectives, commentaries and policy analyses

Evidence-based scholarly discussion of pharmaceutical science, technology, regulation, medicine use or pharmacy practice.

Current length guidance
Article type	Word guidance	Abstract and keywords
Original research	6,000–8,000 words	Structured abstract, up to 250 words; 5–12 keywords
Review article	8,000–10,000 words	Structured abstract, up to 250 words; 5–12 keywords
Short communication or technical note	2,500–3,500 words	Abstract up to 250 words; 5–12 keywords
Method or protocol	4,000–6,000 words	Abstract up to 250 words; 5–12 keywords
Case report	Concise account focused on the case and its pharmaceutical significance	Abstract up to 250 words; 5–12 keywords
Perspective, commentary or policy analysis	Length proportionate to the argument	Concise abstract up to 250 words; 5–12 keywords

Word-count convention

Word guidance excludes references, tables and figure legends.

Manuscript file and structure

Use a clear structure suited to the article type and provide enough detail for editorial assessment and independent review.

File format

DOCX is preferred. Use a 12-point readable font, double spacing, 1-inch margins, page numbers and continuous line numbering where possible.

Title page

Use a title of no more than 30 words and a running title of up to 60 characters. Include complete author names, affiliations, corresponding-author contact details and ORCID iDs where available.

Abstract and keywords

Use Background, Methods, Results and Conclusion headings for research studies. Adapt the abstract to the case or review format where appropriate. Define abbreviations and provide 5–12 precise keywords.

Main text

Original research, including clinical and observational studies, normally uses Introduction, Materials and Methods, Results, Discussion and Conclusion. Case reports should include context, patient information, a clinical timeline, medicine exposure or intervention, outcomes and discussion. Reviews should state their question and approach to selecting and evaluating evidence. Include declarations and references.

Units and nomenclature

Use SI units, define abbreviations, use generic drug names first and apply standard gene, protein and chemical nomenclature.

Cover letter

State the article type, central pharmaceutical contribution, originality, prior dissemination, conflicts and any ethics or trial-registration information.

Pharmaceutical reporting

Report the information relevant to the study type; requirements should support evaluation and reproducibility without forcing irrelevant fields.

Formulation and composition

Report quantities, grades, critical material attributes, preparation sequence, controls and characterization needed to understand and reproduce the product.

Analytical and bioanalytical methods

State intended use, calibration and range, accuracy, precision, selectivity or specificity, sensitivity and robustness or stability evidence as applicable.

Stability

State storage conditions, packaging where relevant, sampling intervals, acceptance criteria and the stability-indicating methods used.

PK and biopharmaceutics

Describe design, dosing, sampling, analytical methods and key parameters in relation to exposure, drug response, safety, bioavailability or the study question.

Materials and provenance

Identify suppliers or manufacturers, catalog or lot identifiers where relevant, and authentication for biological materials and cell lines.

Manufacturing and process studies

Report equipment and scale, critical process parameters, critical quality attributes and controls sufficient for evaluation and reproduction.

Drug discovery and pharmacology

Drug or target identity, dose and exposure, assay suitability, controls, selectivity, response measures and the limits of mechanistic or therapeutic claims.

Natural products and pharmacognosy

Authenticated source material, extraction and characterization, batch or constituent information, appropriate biological controls and evidence for safety and activity.

Clinical research and pharmacy practice

Population, medicine exposure or pharmacy intervention, relevant outcomes, confounding, ethics, consent and transparent interpretation of associations.

Case reports and computational studies

For cases, report the clinical timeline, medicine exposure, alternative explanations and required consent. For computation, report data provenance, evaluation, validation and limitations.

Statistics, figures, reporting and declarations

Methods, visual evidence and policy declarations must be complete and internally consistent.

Statistics and reproducibility

Report sample sizes, replicates, effect estimates and confidence intervals where relevant
Identify tests, assumptions, software and versions
Describe randomization, blinding, exclusions and multiple-comparison adjustments where applicable
Separate exploratory from confirmatory analyses

Study reporting

Use the applicable reporting guidance, including CONSORT, STROBE, PRISMA, CARE, STARD or ARRIVE. The EQUATOR Network provides the current guideline library.

Figures, tables and supporting files

Submit figures separately at 300 dpi or higher with descriptive captions
Use editable tables rather than images and define abbreviations in notes
Identify image adjustments and retain original source files
Obtain permission for reused material
Name supplementary files clearly and cite them in the manuscript

Required declarations

Include author contributions, funding and sponsor role, competing interests, data and code availability, material provenance, ethics approval, consent and clinical-trial registration where applicable.

Peer review

Peer review: Single-blind by default; double-blind review is available on request.

For double-blind review, remove author names, affiliations, acknowledgments, funding details, institution names, and other identifying information from the reviewer manuscript. Provide identifying information separately in the title-page file or submission form.

References and citation format

Use Vancouver style, number sources in order of citation and include DOI links where available.

Reference format models
Source	Required order
Journal article	Author surname and initials. Article title. Journal title. Year;volume(issue):pages. DOI.
Book or chapter	Author surname and initials. Chapter title. In: Book title. Edition. City: Publisher; year. Pages.
Web page	Organization or author. Page title. Site title. Update date. URL. Access date.
Dataset	Creator. Dataset title. Repository; version, year. DOI or persistent identifier.
Preprint	Author. Manuscript title. Preprint server. Year. DOI or persistent URL. Identify as a preprint.
Trial registration	Registry. Registered study title. Identifier. Registration date. Persistent URL.

Verified JAPST example

Patil NS, Suryawanshi HS, Shaikh AZ, Pawar SP. A Review on Drug Design by the Application of Computer. J Adv Pharm Sci Technol. 2022;3(1):13–17. doi:10.14302/issn.2328-0182.japst-22-4363.

Submission, revision and final checklist

Use one approved route for the manuscript and respond to any revision request against the decision letter.

Scope and article type confirmed
Title page and reviewer manuscript prepared as applicable
Abstract, keywords and required sections complete
Figures, tables and supporting files supplied separately
References checked and DOI links included where available
Authorship, contributions, funding and conflicts declared
Ethics, consent and trial registration reported where applicable
Data-availability and material-provenance statements included
Permissions obtained for reused material
Material AI-assisted use disclosed

Revisions

The decision letter states the revision deadline and required response. Address every reviewer and editor point, provide a point-by-point response and submit clean or marked files as requested.

After acceptance

The article processing charge is invoiced only after acceptance. Authors review the proof, and the final article is published under CC BY 4.0. See the APC page, Copyright and License page and Indexing and Discoverability page for the authoritative terms.

Primary

ManuscriptZone

Submit and manage the manuscript in the publisher's editorial system.

Open ManuscriptZone

Alternative

Simple submission form

Use the publisher's manuscript submission form.

Open submission form

Assisted

Editorial office

Email the manuscript and supporting files to [email protected].

Email the editorial office

One route per manuscript

Authors must use only one submission route for the same manuscript.

Journal of Advanced Pharmaceutical Science and Technology